Impact of AIT on Allergic Rhinitis and Asthma
NCT04125888
·
clinicaltrials.gov ↗
COMPLETED
Status
92048
Enrollment
INDUSTRY
Sponsor class
Conditions
Allergy
Respiratory Disease
Interventions
DRUG:
Allergy immunotherapy (AIT)
Sponsor
ALK-Abelló A/S